Helix BioPharma Financial Overview
Helix BioPharma's market cap is currently C$155.81M. The company's EPS TTM is C$-0.013; its P/E ratio is -24.79; Helix BioPharma is scheduled to report earnings on December 12, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
